Pacific Biosciences of California, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
154.98 |
156.23 |
186.53 |
240.03 |
293.49 |
299.47 |
| Przychód Δ r/r |
0.00% |
0.80% |
19.40% |
28.68% |
22.27% |
2.04% |
| Przychód (min) |
154.73 |
149.52 |
165.67 |
234.49 |
274.91 |
280.50 |
| Przychód (max) |
155.13 |
164.85 |
202.18 |
245.58 |
310.04 |
316.36 |
| EBITDA (średnia) |
-108.67 |
-109.55 |
-130.79 |
-168.31 |
-205.80 |
-209.99 |
| EBIT (średnia) |
-112.33 |
-113.23 |
-135.19 |
-173.97 |
-212.72 |
-217.05 |
| EBIT % |
-72.48% |
-72.48% |
-72.48% |
-72.48% |
-72.48% |
-72.48% |
| Zysk netto (średni) |
-450.39 |
-283.15 |
-181.45 |
-123.34 |
-107.27 |
-106.70 |
| Zysk netto % |
-290.61% |
-181.24% |
-97.28% |
-51.39% |
-36.55% |
-35.63% |
| EPS (średnia) |
-1.35 |
-0.98 |
-0.52 |
-0.44 |
-0.37 |
-0.37 |
| Liczba analityków (Przychody) |
9 |
7 |
11 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
8 |
8 |
7 |
3 |
1 |
1 |
| symbol |
PACB |
PACB |
PACB |
PACB |
PACB |
PACB |